JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M111728200 on February 21, 2002

J. Biol. Chem., Vol. 277, Issue 19, 16498-16504, May 10, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/19/16498    most recent
M111728200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harper, C. C.
Right arrow Articles by Gould, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harper, C. C.
Right arrow Articles by Gould, S. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Peroxisomal Membrane Protein Import Does Not Require Pex17p*

Courtney C. HarperDagger , Sarah T. SouthDagger , J. Michael McCaffery§, and Stephen J. GouldDagger

From the Dagger  Department of Biological Chemistry, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205 and the § Integrated Imaging Center, Department of Biology, The Johns Hopkins University, Baltimore, Maryland 21218

Received for publication, December 9, 2001, and in revised form, February 19, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Of the ~20 proteins required for peroxisome biogenesis, only four have been implicated in the process of peroxisomal membrane protein (PMP) import: Pex3p, Pex16p, Pex17p, and Pex19p. To improve our understanding of the role that Pex17p plays in PMP import, we examined the behavior of PMPs in a Pichia pastoris pex17 mutant. Relative to wild-type cells, pex17 cells appeared to have a mild reduction in PMP stability and slightly aberrant PMP behavior in subcellular fractionation experiments. However, we also found that the behavior of PMPs in the pex17 mutant was indistinguishable from PMP behavior in a pex5 mutant, which has no defect in PMP import, and was far different from PMP behavior in a pex3 mutant, which has a bona fide defect in PMP import. Furthermore, we found that a pex14 mutant, which has no defect in PMP import, lacks detectable levels of Pex17p. Based on these and other results, we propose that Pex17p acts primarily in the matrix protein import pathway and does not play an important role in PMP import.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Eukaryotic cells contain specialized organelles that enhance their metabolic efficiency. Peroxisomes are a class of single-membrane bound organelle that play important roles in lipid metabolism in virtually all eukaryotes (1-3). Although eukaryotic cells can survive without peroxisomes, defects in peroxisome biogenesis have significant metabolic and developmental consequences. In humans, severe defects in peroxisome biogenesis cause Zellweger syndrome, a lethal neurological disorder (4, 5), and in yeast such defects eliminate growth on fatty acids, an important carbon and energy source in natural environments (3).

Approximately 20 PEX genes are required for peroxisome biogenesis (6). Two major classes of peroxins have been identified. Most PEX genes are required for import of peroxisomal matrix enzymes but are not required for peroxisome membrane biogenesis or peroxisomal membrane protein (PMP)1 import. PEX5, which encodes the import receptor for most newly synthesized peroxisomal matrix enzymes, is the exemplar of this class (7-13). The second major class of PEX genes is required for the synthesis of peroxisomal membranes and/or the import of PMPs; this group includes PEX3, PEX16, PEX17, and PEX19 (4, 14). Pex3p is an integral PMP that is necessary for the formation of peroxisomes. Yeast and human pex3 mutants lack detectable peroxisomal structures, and PMPs are either rapidly degraded or mislocalized to the mitochondrion in these cells (8, 15). Similar phenotypes are observed in cells lacking Pex19p (8, 16, 17), a putative import receptor/chaperone for newly synthesized PMPs (17, 18) that interacts with PEX3 (19-21). Human PEX16, like PEX3 and PEX19, is also required for peroxisome membrane biogenesis and PMP import (22, 23), although it seems to function differently in the yeast Yarrowia lipolyitca (24) and appears to be absent from the yeast Saccharomyces cerevisiae (25). The fourth peroxin implicated in PMP biogenesis is Pichia pastoris Pex17p (26). This peroxin was identified in the yeast P. pastoris in a screen for mutants that are defective in the import of a PMP-GFP fusion protein (26). Furthermore, the pex17Delta mutant was thought to import PMPs less efficiently than wild-type cells. Based on these results, Snyder et al. (26) and Subramani et al. (14) have proposed that Pex17p plays a specific role in PMP import, with the matrix protein import defect of pex17Delta cells resulting indirectly from this defect in PMP biogenesis. These results are somewhat different from those reported for S. cerevisiae PEX17, which appears to participate only in matrix protein import (8, 27).

To improve our understanding of PMP import we began an investigation into the role of PEX17 in this process. An analysis of pex17Delta cells revealed that they do have slightly reduced levels of PMPs and that PMPs displayed an aberrant fractionation behavior, at least as compared with wild-type (WT) cells. However, we also observed these changes in pex5Delta mutants, which are impaired in matrix protein import but unaffected in PMP import or peroxisome membrane biogenesis. Furthermore, pex17Delta cells show a phenotype that is very different from that of pex3Delta cells, which have a clear role in PMP biogenesis. Based on these and other results, we conclude that P. pastoris Pex17p plays an important role in peroxisomal matrix protein import but has no detectable role in PMP import or any other aspect of PMP biogenesis.

    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Yeast Strains-- The yeast strains used in this study are listed in Table I. The pex3Delta mutant was generated by PCR-mediated gene disruption (28). A DNA fragment containing the KanMX cassette (28), 90 base pairs 5' of the PEX3 open reading frame and 257 base pairs 3' of the PEX3 open reading frame was generated by PCR and introduced into SGY55 by electroporation (29). Transformants were selected on YPD plates containing 300 µg/ml G418. Replacement of the PEX3 open reading frame with the KanMX cassette was confirmed by PCR. Cells were grown in YPD (1% yeast extract, 2% peptone, 2% dextrose), SYOLT (0.17% yeast nitrogen base without amino acids or ammonium sulfate, 0.5% ammonium sulfate, 0.05% L-histidine, 0.05% yeast extract, 0.18% oleic acid, 0.02% Tween 40), or SM (0.17% yeast nitrogen base without amino acids or ammonium sulfate, 0.5% ammonium sulfate, 0.05% l-histidine, 0.5% methanol) as described (29).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Yeast strains

Antibodies, Protein Extracts, and Western Blotting-- Antibodies to P. pastoris Pex10p and Pex12p have been described previously (30, 31). Anti-Pex13p antibodies were a generous gift from D. Crane (Griffith University, Brisbane, Australia). We raised antibodies to a 19-amino acid peptide containing the COOH-terminal 15 amino acids of P. pastoris Pex3p (NH2-CKKKELNDLSASVYSNFDP-COOH). Anti-Pex17p antibodies were raised to an MBP-Pex17p fusion protein expressed in and purified from Escherichia coli (amino acids 1-267). Whole-cell lysates were prepared as described (29) and detected by immunoblotting (29). All differential centrifugation and density gradient centrifugation experiments were performed as described previously (29).

Enzyme Assays-- Assays were performed on supernatant and pellet fractions of postnuclear supernatants generated from oleic acid-induced pex17Delta , pex5Delta , and WT strains spun for 1 h at 250,000 × g. Glyceraldehyde-3-phosphate dehydrogenase activity was determined at 25 °C by increasing A340 over 160 s. Each fraction was diluted 30-fold into the reaction buffer (13 mM sodium pyrophosphate, pH 8.5, 26 mM sodium arsenate, 25 µM NAD+, 3 mM dithiothreitol), and the reaction was started with the addition of DL-glyceraldehyde-3-phosphate to a concentration of 500 µM. Succinate dehydrogenase activity was determined by incubating 25 µl of each lysate at 37 °C in the presence of 50 mM potassium phosphate, pH 6.8, 0.1% p-iodonitrotetrazolene, and 50 mM Na2 succinic acid for 10 min. The reactions were stopped by the addition of trichloroacetic acid to 5%. Color was developed by the addition of 1 ml of ethylene glycol monomethyl ether, and the A440 was read.

Electron Microscopy-- Strains were induced in SM media as described above. Yeast cells (at 24 °C) were pelleted, washed in ddH20, 3% glutaraldehyde, 100 mM cacodylate buffer, 5 mM CaCl2, and 5 mM MgCl2 for 1 h at room temperature, pH 7.4. Cells were then washed briefly in 100 mM cacodylate buffer, pH 7.4, dispersed/embedded in 2% low temperature agarose (~1:1), cooled, and subsequently cut into small blocks (~1 mm3). Blocks were then post-fixed in 4% KMnO4, prepared in ddH2O for 1 h at room temperature, washed thoroughly (4 times, 10 min total) in ddH2O, treated with 0.5% sodium meta-periodate for 15 min at room temperature, washed twice in ddH2O, and placed into filtered 2% uranyl acetate overnight at room temperature (in the dark). Blocks were then rapidly dehydrated through a graded series of EtOH (4 °C), followed by three washes in 100% EtOH (15 min each) and then two washes with propylene oxide, and placed into a 50:50 mixture of propylene oxide and Spurr resin. Samples were incubated overnight under vacuum and were subsequently given two changes of Spurr resin over 6-8 h and left overnight in a third change under vacuum throughout the next day. The samples were placed in beam capsules containing fresh Spurr resin, which were placed in a polymerizing oven at 80 °C for 24-48 h. 60-nm sections were cut on a Leica UCT ultramicrotome, collected onto 400-mesh nickel grids, post-stained with lead citrate (2-5 min), and observed in a Philips EM 410 at 80 kV.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

PMP Abundance and Distribution in P. pastoris pex17Delta Cells-- Previous studies have shown that defects in PMP import result in rapid turnover and low steady state levels of most PMPs (8, 15-17, 23, 32). To determine whether this was also true for cells lacking Pex17p, we examined the abundance of three integral PMPs in a P. pastoris pex17Delta strain: Pex3p (33), Pex10p (30), and Pex12p (31). To control for the specificity of any phenotypes we might detect, we also examined the phenotypes of pex3Delta cells, which have a well established defect in PMP import (8, 15, 33), and pex5Delta cells, which are defective in matrix protein import but are not defective in PMP import (7-9). These strains were grown in YPD to mid-log phase, washed, and incubated in oleate-containing medium for 18 h. Cells were then harvested and lysed, and total cellular protein was collected by trichloroacetic acid precipitation. Equal amounts of protein from each strain were separated by SDS-PAGE and blotted with anti-PMP antibodies. As previously reported for pex3Delta mutants of humans and S. cerevisiae, P. pastoris pex3Delta mutants had low steady state levels of PMPs (Fig. 1). Steady state levels of Pex3p, Pex10p, and Pex12p were also somewhat lower in pex17Delta cells than in WT cells, although they were clearly higher than in the pex3Delta strain. The levels of these three PMPs in the pex5Delta cells were the same as in pex17Delta cells. This was somewhat surprising given that all prior studies of PMP biogenesis in pex5Delta mutants have supported the hypothesis that Pex5p has no role in PMP import (7-13, 34).


View larger version (45K):
[in this window]
[in a new window]
 
Fig. 1.   PMP abundance in WT, pex3Delta , pex5Delta , and pex17Delta cells. Equal amounts of total cellular protein from WT, pex3Delta , pex5Delta , and pex17Delta cells were separated by SDS-PAGE, transferred to membranes, and probed with antibodies for Pex3p, Pex10p, and Pex12p. The Pex12p antibody detected two proteins, the larger of which is Pex12p (arrow).

To better understand the role of Pex17p in PMP import, we next used subcellular fractionation experiments in an attempt to assess the import of PMPs in pex17Delta cells, as well as in pex3Delta , pex5Delta , and WT controls. Each strain was grown in YPD, incubated in oleate-containing medium for 18 h, and converted to spheroplasts. Cells were lysed in a Dounce homogenizer and cleared of nuclei and cell debris by low speed centrifugation. The resulting postnuclear supernatants (PNSs) were separated by centrifugation at 25,000 × g for 30 min. Equal proportions of each fraction were then separated by SDS-PAGE and blotted with antibodies to Pex3p, Pex10p, and Pex12p (Fig. 2). The levels of these PMPs in extracts prepared from pex3Delta cells were below the level of detection. In cells lacking Pex17p, ~20-30% of the Pex10p and Pex12p and ~50% of the Pex3p were detected in the 25kg supernatant, which could be interpreted as evidence that pex17Delta cells have a partial PMP import defect. However, pex5Delta cells have a similar phenotype, raising questions about whether this assay is an accurate measure of PMP import.


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 2.   PMP distribution in 25,000 × g supernatant and pellet fractions of WT, pex3Delta , pex5Delta , and pex17Delta cells. PNSs were generated from oleic acid-induced WT, pex3Delta , pex5Delta , and pex17Delta cells and spun for 30 min at 25,000 × g. Equal portions of the supernatant (S) and pellet (P) fractions were separated by SDS-PAGE, transferred to membranes, and probed with antibodies to Pex3p, Pex10p, and Pex12p.

Cells Lacking Pex17p Do Not Accumulate a Pool of Soluble, Cytoplasmic PMPs-- Snyder et al. (26) previously reported that the PMPs present in the 25,000 × g supernatant fraction of pex17Delta mutant extracts were largely resistant to sedimentation at higher speeds (100,000 × g). Based in part on this result, they concluded that pex17Delta cells have a significant pool of soluble, cytosolic PMPs (26). However, other studies have suggested that cell homogenates contain significant levels of peroxisome-derived "microsomes" that may pellet only at higher speeds (35-38). Postnuclear supernatants were again generated from oleic acid-induced pex17Delta , pex5Delta , and WT strains and spun for 1 h at 250,000 × g. Enzymatic assays of glyceraldehyde-3-phosphate dehydrogenase and succinate dehydrogenase, which are cytosolic and mitochondrial enzymes, respectively, demonstrate that these conditions are sufficient to pellet organelles but not soluble proteins. Equal proportions of each fraction were then separated by SDS-PAGE, transferred to membranes, and probed with antibodies to Pex3p, Pex10p, and Pex12p (Fig. 3A). Under these conditions, all three PMPs were found primarily in the pellet fraction of pex17Delta cells. Similar results were observed for the pex5Delta mutant. Thus, it appears that PMPs present in the 25,000 × g supernatant of pex17Delta and pex5Delta mutants do not represent pools of soluble, cytosolic PMPs.


View larger version (42K):
[in this window]
[in a new window]
 
Fig. 3.   PMPs of pex17Delta and pex5Delta cells sediment at 250,000 × g. A, PNSs prepared from WT, pex5Delta , and pex17Delta strains were spun at 250,000 × g for 1 h. Glyceraldehyde-3-phosphate dehydrogenase (GAPD; a cytosolic enzyme) and succinate dehydrogenase (SDH; a mitochondrial enzyme) activities were determined as controls. B, levels of PMPs extracted by high pH treatment. PNSs were extracted with 0.1 M Na2CO3, pH 11.5, and then spun at 250,000 × g for 1 h. Equal proportions of supernatant (S) and pellet (P) fractions were subjected to immunoblot with antibodies to Pex3p, Pex10p, and Pex12p.

The sedimentation of Pex3p, Pex10p, and Pex12p from pex17Delta and pex5Delta lysates could reflect the insertion of these proteins into peroxisomal membranes. However, their sedimentation behavior could also reflect a more complicated situation. For example, a portion of each PMP may be properly inserted into peroxisome membranes, whereas other subsets of these PMPs may be only peripherally associated with membranes or may exist in large protein aggregates. To determine the proportion of each PMP that was inserted into the peroxisome membrane in each cell type, we incubated the PNSs from pex17Delta , pex5Delta , and WT strains with 0.1 M Na2CO3, pH 11.5 (39), to extract non-integral proteins from cellular membranes. Integral membrane proteins were then collected in the pellet fraction by centrifugation at 250,000 × g for 1 h. Equal proportions of each fraction were then processed for immunoblot using antibodies to Pex3p, Pex10p, and Pex12p (Fig. 3B). In both the pex17Delta and pex5Delta mutants, ~50% of their PMPs were released to the supernatant by carbonate extraction. The amounts of PMPs released from WT peroxisome membranes were similar to the amounts of PMPs released from pex17Delta and pex5Delta mutants, although they corresponded to only 10% of the total PMPs in WT cells as opposed to 50% of the PMPs in these two mutants.

The P. pastoris pex14 Mutant Lacks Both Pex14p and Pex17p-- As part of our basic characterization of Pex17p, we examined its abundance in an array of P. pastoris pex mutants. We generated antibodies to recombinant Pex17p. These antibodies recognize a protein of ~25 kDa (the predicted molecular mass of Pex17p is 30,497 Da) in P. pastoris cell extracts. The protein recognized by these antibodies is absent from pex17Delta cells, colocalizes with peroxisomes in density gradient centrifugation experiments, and behaves as an integral PMP, indicating that these antibodies are specific for Pex17p (Fig. 4). These antibodies were then used to assess the abundance of Pex17p in the pex1, pex2, pex3, pex4, pex5, pex6, pex8, pex10, pex12, pex14, pex17, and pex22 mutants (Fig. 5). Whole cell lysates were generated by alkaline lysis, and equal amounts of protein from each strain were separated by SDS-PAGE, transferred to membranes, and probed with anti-Pex17p antibodies. As a control, we determined the levels of Pex13p in these same samples. As expected, Pex17p was absent from the pex17Delta mutant. Levels were also reduced in the pex3Delta mutant, consistent with the rapid degradation of all known PMPs in these cells (8, 15, 32) (see Fig. 1). However, we observed that Pex17p was also undetectable in the P. pastoris pex14 mutant, and it is interesting to note that the pex14 mutants of P. pastoris (40), S. cerevisiae (8, 41), and mammalian cells (42) have all been reported to import PMPs normally. Pex17p abundance was slightly reduced in cells lacking Pex13p, another Pex14p-binding protein (40, 41, 43). Equal loading and transfer of the pex14 sample can be deduced from the fact that Pex13p levels were normal in this strain.


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 4.   Specificity of anti-Pex17p antibodies. A, equal amounts of total cellular protein from WT and pex17Delta cells were processed for immunoblot with anti-pex17p antibodies. B, PNS was generated from oleic acid-induced WT cells; this was then separated by centrifugation for 30 min at 25,000 × g. The resulting cytosolic supernatant (S) and organelle pellet (P) were separated by SDS-PAGE, and the distribution of Pex17p was examined. Pex17p is localized to the peroxisomal pellet fraction. C, a WT PNS ± 0.1 M Na2CO3, pH 11.5, was separated at 250,000 × g for 1 h to pellet all membranes. The resulting fractions were analyzed by Western blot to determine the distribution of Pex17p. Pex17p is found predominantly in the pellet fraction even after carbonate extraction, indicating that it is an integral PMP. D, a WT PNS was fractionated by density centrifugation in a 42.5-15% Nycodenz gradient. Fractions were assayed for catalase (------) and mitochondrial succinate dehydrogenase (- - -) activity as well as for the presence of Pex17p by immunostaining.


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 5.   Pex17p is undetectable in pex14- cells. Whole-cell protein extracts were generated from P. pastoris pex mutants. Equal amounts of protein from each sample were separated by SDS-PAGE and analyzed by Western blot. Pex17p is absent from pex17Delta cells, is found at low levels in pex3Delta cells, and is absent from pex14- cells. Antibodies against Pex13p were used as a loading control.

Cells Lacking Pex17p Contain Peroxisomes That Resemble Peroxisomes of pex5Delta Cells-- The hypothesis that Pex17p may not play a role in PMP import predicts that pex17Delta cells would display peroxisome morphologies that are largely indistinguishable from those of pex5Delta and pex14Delta cells. Electron micrographic examination of these mutants supports this hypothesis (Fig. 6). After induction of peroxisomes by growth on methanol, wild-type cells accumulate many large, electron-dense peroxisomes. In contrast, the pex3Delta mutant, that has a bona fide PMP import defect, lacks detectable peroxisomal structures. Peroxisomal structures of similar abundance and morphology can be detected in the pex17Delta , pex5Delta , and pex14Delta mutants. These are much smaller and contain less electron-dense material than WT cells, consistent with the matrix protein import defects in these pex mutants.


View larger version (133K):
[in this window]
[in a new window]
 
Fig. 6.   Peroxisomes of pex17Delta cells are similar to those of pex5Delta and pex14Delta cells. A, wild-type cells clearly demonstrate large/well defined peroxisomes. B, pex3Delta cells show the absence of peroxisomes. C and D, pex5Delta cells have fewer/smaller peroxisomes. E-G, pex17Delta cells have fewer/smaller peroxisomes and peroxisomes of heterogeneous morphology. H-K, pex14Delta cells also have smaller/spherical peroxisomes. n, nucleus; m, mitochondria; p, peroxisomes; V, vacuole. Bars = 1 µm (A, B, C, E, and H) and 0.1 µm (D, F, G, I, J, and K).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

We investigated the hypothesis that Pex17p plays an important role in PMP import (14, 26). The first consideration in trying to determine whether a particular peroxin participates in matrix protein import or PMP import is to determine whether the peroxin is essential for PMP import. In the present study we established that P. pastoris pex17Delta cells are able to import PMPs and assemble peroxisome membranes, demonstrating conclusively that Pex17p is not required for PMP import. This aspect of the pex17Delta phenotype contrasts sharply with that of a bona fide PMP import mutant, pex3Delta , in which PMPs are degraded rapidly because of their PMP import defect (8, 15, 32) and are virtually undetectable.

The second consideration in assessing the role of Pex17p in PMP import is to determine whether its loss has a partial yet specific effect on PMP import. We did observe a slight reduction in PMP abundance in the proportion of PMPs that were inserted into the peroxisome membrane in P. pastoris pex17Delta cells. However, the question is whether any mutant that is defective in peroxisomal matrix enzyme import will also display these phenotypes or whether they reflect a specific role for Pex17p in PMP import. We observed that cells lacking Pex5p also displayed these phenotypes. Pex5p is the import receptor for PTS1-containing peroxisomal matrix enzymes, and several previous studies have concluded that Pex5p does not play any role in PMP import (7-13, 34). Therefore, it is reasonable to conclude from these data that Pex17p is unlikely to play a specific role in PMP import.

The phenotypes of the P. pastoris pex14 mutant (40) contribute independent evidence that P. pastoris Pex17p does not play a specific role in PMP import. Pex14p appears to function as the docking factor for the PTS receptors in yeast (40, 41, 44) and mammalian cells (42, 45). Numerous studies of pex14 mutants (8, 40-42, 44), including one of the P. pastoris pex14 mutant (40), have reached the conclusion that pex14 mutants have no detectable defect in PMP import. We found that Pex17p levels are below the limit of detection in pex14 cells, demonstrating that the pex14 mutant is the equivalent of a pex14,pex17 double mutant. Because the P. pastoris pex14 mutant does not display any detectable defect in PMP import (40), it is highly unlikely that the P. pastoris pex17Delta mutant could have a PMP import defect.

The final argument against a role for Pex17p in PMP import comes from studies of S. cerevisiae Pex17p (27). Peroxisomal matrix protein import is severely affected in S. cerevisiae pex17Delta mutants, but PMP import appears to be normal in these cells. In a systematic side-by-side analysis of S. cerevisiae pex mutants, Hettema et al. (8) established that PMP abundance and distribution in pex17Delta cells was the same as it was in the pex1, pex2, pex4, pex5, pex6, pex7, pex8, pex10, pex11, pex12, pex13, pex14, and pex15 mutants. Although there are some peroxins that function differently in different species, these are rare; and there is no precedent for such differences between P. pastoris and S. cerevisiae peroxins.

In addition to casting doubt on the hypothesis that Pex17p plays an important role in PMP import (14, 26), our data revealed that the fractionation behavior of PMPs in WT cells may be quite different from that observed in pex mutants that have no specific defect in PMP import. The pool of PMPs seen in pex5Delta and pex17Delta mutants that did not sediment at 25,000 × g, which is sufficient to pellet most peroxisomes of WT cells (29) (see Fig. 2), was also seen in other matrix protein import mutants, including the pex4Delta , pex10Delta , and pex14 mutants (data not shown). One explanation for these results could be that the extremely small size of peroxisomes in pex5Delta , pex17Delta , and many other pex mutants precludes their quantitative sedimentation at speeds that are known to sediment the large, enzyme-rich peroxisomes of WT cells. After all, sedimentation behavior in these experiments is primarily a function of size rather than density, with larger structures being pelleted at lower centrifugation speeds and shorter centrifugation times. As for the observation that a higher proportion of PMPs can be extracted by high pH buffer in these mutants (~50%) as compared with WT cells (~10%), there is no difference between these mutants and WT cells in regard to the absolute amounts of PMPs extracted by high pH treatment (see Fig. 3B). The high pH-extractable PMPs we detected in both WT cells and pex mutants may include PMPs that are bound to the membrane but not yet inserted in the bilayers or merely large protein aggregates.

Although the above arguments indicate that there may, in fact, be no actual defect in PMP import in the pex5Delta , pex17Delta , and other pex mutants, it is also possible that any mutant that is defective in matrix enzyme import will display an ancillary, nonspecific impairment in PMP import. Peroxisomes in these pex mutants are metabolically inactive, are far smaller than normal peroxisomes, and appear to have far less surface area than peroxisomes of WT cells. This situation may delay PMP import, resulting in the accumulation of PMPs on the membrane surface and/or in protein aggregates, which could also explain our fractionation data. Regardless of the actual reason for our observation, it is clear that an appropriate set of WT and mutant control strains is required to distinguish between specific and nonspecific defects in PMP import.

Although the simplest interpretation of our data is that Pex17p acts directly in matrix protein import and plays no specific role in PMP import, it is not possible to exclude completely the possibility that Pex17p plays a direct, minor role in PMP import. However, if the available data are to be interpreted as evidence for such a role, then one must also conclude that Pex5p and Pex14p participate directly in PMP import, a conclusion that contradicts a large body of evidence (7-13, 40-42, 44).

In addition to showing that Pex17p is unlikely to play an important role in PMP import and most likely plays a direct role in peroxisomal matrix protein import, we observed that Pex17p is undetectable in the absence of Pex14p. Whether this dependence reflects a defect in Pex17p synthesis or an enhancement in Pex17p degradation remains to be determined, although a defect in Pex17p stability would appear to be the more likely explanation. If true, this would lend additional support to the hypothesis that Pex17p acts together with Pex14p, which was originally proposed by Kunau and co-workers (27) based on the interaction of Pex17p and Pex14p in vitro and in vivo. The absence of Pex17p from pex14 mutants also raises new questions about which phenotypes of pex14 mutants are caused by the loss of Pex14p and which result from the absence of Pex17p.

    FOOTNOTES

* This work was supported by grants from the National Institutes of Health (DK45787 and DK59479 to S. J. G.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Dept. of Biological Chemistry, The Johns Hopkins University School of Medicine, Baltimore, MD 21205. Tel.: 410-955-3424 and -3085; Fax: 410-955-0215; E-mail: sgould@jhmi.edu.

Published, JBC Papers in Press, February 21, 2002, DOI 10.1074/jbc.M111728200

    ABBREVIATIONS

The abbreviations used are: PMP, peroxisomal membrane protein; WT, wild type; PNS, postnuclear supernatant.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Wanders, R. J., Vreken, P., Ferdinandusse, S., Jansen, G. A., Waterham, H. R., van Roermund, C. W., and Van Grunsven, E. G. (2001) Biochem. Soc. Trans. 29, 250-267[CrossRef][Medline] [Order article via Infotrieve]
2. Wanders, R. J., and Tager, J. M. (1998) Mol. Aspects Med. 19, 69-154[Medline] [Order article via Infotrieve]
3. Hettema, E. H., and Tabak, H. F. (2000) Biochim. Biophys. Acta 1486, 18-27[Medline] [Order article via Infotrieve]
4. Gould, S. J., and Valle, D. (2000) Trends Genet. 16, 340-344[CrossRef][Medline] [Order article via Infotrieve]
5. Gould, S. G., Valle, D., and Raymond, G. V. (2001) in The Metabolic and Molecular Bases of Inherited Disease (Scriver, C. R. , Beaudet, A. L. , Sly, W. S. , and Valle, D., eds), 8th Ed., Vol. 2 , pp. 3181-3217, McGraw-Hill, New York
6. Sacksteder, K. A., and Gould, S. J. (2000) Annu. Rev. Genet. 34, 623-652[CrossRef][Medline] [Order article via Infotrieve]
7. McCollum, D., Monosov, E., and Subramani, S. (1993) J. Cell Biol. 121, 761-774[Abstract/Free Full Text]
8. Hettema, E. H., Girzalsky, W., van Den Berg, M., Erdmann, R., and Distel, B. (2000) EMBO J. 19, 223-233[CrossRef][Medline] [Order article via Infotrieve]
9. Chang, C. C., South, S., Warren, D., Jones, J., Moser, A. B., Moser, H. W., and Gould, S. J. (1999) J. Cell Sci. 112, 1579-1590[Abstract]
10. Dodt, G., Braverman, N., Wong, C., Moser, A., Moser, H. W., Watkins, P., Valle, D., and Gould, S. J. (1995) Nat. Genet. 9, 115-124[CrossRef][Medline] [Order article via Infotrieve]
11. van der Leij, I., Franse, M. M., Elgersma, Y., Distel, B., and Tabak, H. F. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 11782-11786[Abstract/Free Full Text]
12. van der Klei, I. J., Hibrands, R. E., Swaving, G. J., Waterham, H. R., Vrieling, E. G., Titorenko, V. I., Cregg, J. M., Harder, W., and Veenhuis, M. (1995) J. Biol. Chem. 270, 17229-17236[Abstract/Free Full Text]
13. Baes, M., Gressens, P., Baumgart, E., Carmeliet, P., Casteels, M., Fransen, M., Evrard, P., Fahimi, D., Declercq, P. E., Collen, D., van Veldhoven, P. P., and Mannaerts, G. P. (1997) Nat. Genet. 17, 49-57[CrossRef][Medline] [Order article via Infotrieve]
14. Subramani, S., Koller, A., and Snyder, W. B. (2000) Annu. Rev. Biochem. 69, 399-418[CrossRef][Medline] [Order article via Infotrieve]
15. South, S. T., Sacksteder, K. A., Li, X., Liu, Y., and Gould, S. J. (2000) J. Cell Biol. 149, 1345-1360[Abstract/Free Full Text]
16. Matsuzono, Y., Kinoshita, N., Tamura, S., Shimozawa, N., Hamasaki, M., Ghaedi, K., Wanders, R. J., Suzuki, Y., Kondo, N., and Fujiki, Y. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 2116-2121[Abstract/Free Full Text]
17. Sacksteder, K. A., Jones, J. M., South, S. T., Li, X., Liu, Y., and Gould, S. J. (2000) J. Cell Biol. 148, 931-944[Abstract/Free Full Text]
18. Jones, J. M., Morrell, J. C., and Gould, S. J. (2001) J. Cell Biol. 153, 1141-1150[Abstract/Free Full Text]
19. Gotte, K., Girzalsky, W., Linkert, M., Baumgart, E., Kammerer, S., Kunau, W.-H., and Erdmann, R. (1998) Mol. Cell. Biol. 18, 616-628[Abstract/Free Full Text]
20. Snyder, W. B., Faber, K. N., Wenzel, T. J., Koller, A., Luers, G. H., Rangell, L., Keller, G. A., and Subramani, S. (1999) Mol. Biol. Cell 10, 1745-1761[Abstract/Free Full Text]
21. Fransen, M., Wylin, T., Brees, C., Mannaerts, G. P., and Van Veldhoven, P. P. (2001) Mol. Cell. Biol. 21, 4413-4424[Abstract/Free Full Text]
22. Honsho, M., Tamura, S., Shimozawa, N., Suzuki, Y., Kondo, N., and Fujiki, Y. (1998) Am. J. Hum. Genet. 63, 1622-1630[CrossRef][Medline] [Order article via Infotrieve]
23. South, S. T., and Gould, S. J. (1999) J. Cell Biol. 144, 255-266[Abstract/Free Full Text]
24. Eitzen, G. A., Szilard, R. K., and Rachubinski, R. A. (1997) J. Cell Biol. 137, 1265-1278[Abstract/Free Full Text]
25. Tabak, H. F., Braakman, I., and Distel, B. (1999) Trends Cell Biol. 9, 447-453[CrossRef][Medline] [Order article via Infotrieve]
26. Snyder, W. B., Koller, A., Choy, A. J., Johnson, M. A., Cregg, J. M., Rangell, L., Keller, G. A., and Subramani, S. (1999) Mol. Biol. Cell 10, 4005-4019[Abstract/Free Full Text]
27. Huhse, B., Rehling, P., Albertini, M., Blank, L., Meller, K., and Kunau, W. H. (1998) J. Cell Biol. 140, 49-60[Abstract/Free Full Text]
28. Baker-Brachmann, C., Davies, A., Cost, G. J., Caputo, E., Li, J., Hieter, P., and Boeke, J. D. (1998) Yeast 14, 115-132[CrossRef][Medline] [Order article via Infotrieve]
29. Crane, D. I., Kalish, J. E., and Gould, S. J. (1994) J. Biol. Chem. 269, 21835-21844[Abstract/Free Full Text]
30. Kalish, J. E., Theda, C., Morrell, J. C., Berg, J. M., and Gould, S. J. (1995) Mol. Cell. Biol. 15, 6406-6419[Abstract]
31. Kalish, J. E., Keller, G. A., Morrell, J. C., Mihalik, S. J., Smith, B., Cregg, J. M., and Gould, S. J. (1996) EMBO J. 15, 3275-3285[Medline] [Order article via Infotrieve]
32. Kinoshita, N., Ghaedi, K., Shimozawa, N., Wanders, R. J. A., Matsuzono, Y., Imanaka, T., Okumoto, K., Suzuki, Y., Kondo, N., and Fujiki, Y. (1998) J. Biol. Chem. 273, 24122-24130[Abstract/Free Full Text]
33. Wiemer, E. A. C., Luers, G. H., Faber, K. N., Wenzel, T., Veenhuis, M., and Subramani, S. (1996) J. Biol. Chem. 271, 18973-18980[Abstract/Free Full Text]
34. Gatto, G. J., Jr., Geisbrecht, B. V., Gould, S. J., and Berg, J. M. (2000) Nat. Struct. Biol. 7, 1091-1095[CrossRef][Medline] [Order article via Infotrieve]
35. Heinemann, P., and Just, W. W. (1992) FEBS Lett. 300, 179-182[CrossRef][Medline] [Order article via Infotrieve]
36. van Roermund, C. W. T., van den Berg, M., and Wanders, R. J. A. (1995) Biochim. Biophys. Acta 1245, 348-358[Medline] [Order article via Infotrieve]
37. Titorenko, V. I., Chan, H., and Rachubinski, R. A. (2000) J. Cell Biol. 148, 29-44[Abstract/Free Full Text]
38. Titorenko, V. I., and Rachubinski, R. A. (2000) J. Cell Biol. 150, 881-886[Abstract/Free Full Text]
39. Fujiki, Y., Hubbard, A. L., Fowler, S., and Lazarow, P. B. (1982) J. Cell Biol. 93, 97-102[Abstract/Free Full Text]
40. Johnson, M. A., Snyder, W. B., Cereghino, J. L., Veenhuis, M., Subramani, S., and Cregg, J. M. (2001) Yeast 18, 621-641[CrossRef][Medline] [Order article via Infotrieve]
41. Albertini, M., Rehling, P., Erdmann, R., Girzalsky, W., Kiel, J. A. K. W., Veenhuis, M., and Kunau, W.-H. (1997) Cell 89, 83-92[CrossRef][Medline] [Order article via Infotrieve]
42. Shimizu, N., Itoh, R., Hirono, Y., Otera, H., Ghaedi, K., Tateishi, K., Tamura, S., Okumoto, K., Harano, T., Mukai, S., and Fujiki, Y. (1999) J. Biol. Chem. 274, 12593-12604[Abstract/Free Full Text]
43. Girzalsky, W., Rehling, P., Stein, K., Kipper, J., Blank, L., Kunau, W. H., and Erdmann, R. (1999) J. Cell Biol. 144, 1151-1162[Abstract/Free Full Text]
44. Komori, M., Rasmussen, S. W., Kiel, J. A., Baerends, R. J., Cregg, J. M., van der Klei, I. J., and Veenhuis, M. (1997) EMBO J. 16, 44-53[CrossRef][Medline] [Order article via Infotrieve]
45. Schliebs, W., Saidowsky, J., Agianian, B., Dodt, G., Herberg, F. W., and Kunau, W. H. (1999) J. Biol. Chem. 274, 5666-5673[Abstract/Free Full Text]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
W. Girzalsky, L. S. Hoffmann, A. Schemenewitz, A. Nolte, W.-H. Kunau, and R. Erdmann
Pex19p-dependent Targeting of Pex17p, a Peripheral Component of the Peroxisomal Protein Import Machinery
J. Biol. Chem., July 14, 2006; 281(28): 19417 - 19425.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
G. P. Lin-Cereghino, L. Godfrey, B. J. de la Cruz, S. Johnson, S. Khuongsathiene, I. Tolstorukov, M. Yan, J. Lin-Cereghino, M. Veenhuis, S. Subramani, et al.
Mxr1p, a Key Regulator of the Methanol Utilization Pathway and Peroxisomal Genes in Pichia pastoris
Mol. Cell. Biol., February 1, 2006; 26(3): 883 - 897.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
S. Leon, L. Zhang, W. H. McDonald, J. Yates III, J. M. Cregg, and S. Subramani
Dynamics of the peroxisomal import cycle of PpPex20p: ubiquitin-dependent localization and regulation
J. Cell Biol., January 3, 2006; 172(1): 67 - 78.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/19/16498    most recent
M111728200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Harper, C. C.
Right arrow Articles by Gould, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harper, C. C.
Right arrow Articles by Gould, S. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?